Description
PF-06447475 inhibits leucine-rich repeat kinase 2 (LRRK2), exhibiting neuroprotective activity. In animal models of Parkinson’s disease, this compound suppresses neuroinflammation and neurodegeneration.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06447475 inhibits leucine-rich repeat kinase 2 (LRRK2), exhibiting neuroprotective activity. In animal models of Parkinson’s disease, this compound suppresses neuroinflammation and neurodegeneration.
| Cas No. | 1527473-33-1 |
|---|---|
| Purity | ≥98% |
| Formula | C17H15N5O |
| Formula Wt. | 305.13 |
| Chemical Name | 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile |
| IUPAC Name | 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile |
| Solubility | DMSO 61 mg/mL Water Insoluble Ethanol Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Daher JP, Abdelmotilib HA, Hu X, et al. LRRK2 Pharmacological Inhibition Abates α-Synuclein Induced Neurodegeneration. J Biol Chem. 2015 Jun 15. [Epub ahead of print]. PMID: 26078453.
Henderson JL, Kormos BL, Hayward MM, et al. Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. J Med Chem. 2015 Jan 8;58(1):419-32. PMID: 25353650.
Smo inhibitor.
Sulfonylurea; ATP-sensitive K+ channel blocker....
Glycosaminoglycan
Glutamine analog; γ-glutamyl transferase, CTP ...
γ-Secretase inhibitor.
Selective cannabinoid receptor 2 (CB2) inverse ...
Pentacyclic triterpene.
Cannabinoid receptor 2 selective agonist.
Inhibitor of TRK.
Flavone found in Scutellaria; prolyl oligopepti...
PORCN inhibitor.
Steroid; glucocorticoid agonist.
Coccidiostat; dihydrofolate reductase inhibitor...
Nitrosourea, DNA cross-linker.
V600E B-Raf inhibitor.
mGluR5 positive modulator.
α1-adrenergic antagonist.
Type A trichothecene mycotoxin produced by Fusa...
Endogenous peptide hormone inolved in gastric e...
mTOR inhibitor.